Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure

Leukemia and Lymphoma

Volumn 29, Issue 1-2, 1998, Pages 205-209

  Kepka, Lucyna ^a   De Lassence, Arnaud ^a   Ribrag, Vincent ^a   Gachot, Bertrand ^a,b   Blot, François ^a   Theodore, Christine ^a   Bonnay, Marc ^a   Korenbaum, Claudine ^a   Nitenberg, Gerard ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Acute renal failure; Folinic acid; High dose methotrexate; Methotrexate toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0031806321     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058397     Document Type: Article

References (11)

1. Allegra, C. L. (1990). Antifolates. In: Cancer Chemotherapy, by B. A. Chabner and J. M. Collins (eds.), pp. 100-153 (J. B. Lippincott Company, Philadelphia).
2. Bertino, J. R. and Lin, J. T. (1993). Antifolates - methotrexate, trimetrexate, 10-Edam. In: Handbook of Chemotherapy in Clinical Oncology, E. Cvitkovic, J. P. Droz, J. P. Armand and S. Khoury (eds.), pp. 349-354 (Scientific Communication International Ltd., Jersey).
3. Garnick, M. B., Mayer, R. J. and Abelson, H. T. (1988). Acute renal failure associated with cancer treatment. In: Acute Renal Failure. B. M. Brenner and J. M. Lazarus (eds.), pp. 621-657 (Churchill Livingstone, New York).
4. Hande, K. R., Balow, J. E., Drake, J. C., Rosenberg, S. A. and Chabner, B. A. (1977). Methotrexate and hemodialysis. Annals of Internal Medicine, 87, 495-496.
5. Ahmad, S., Shen, F. H. and Bleyer, W. A. (1978). Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Archives of Internal Medicine, 138, 1146-1147.
6. Gibson, T. P., Reich, S. D., Krumlovsky, F. A., Ivanovich, P. and Gonczy, C. (1978). Hemoperfusion for methotrexate removal. Clinical Pharmacology and Therapeutics, 23, 351-355.
7. Howell, S. B., Blair, H. E., Uren, J. and Frei, E. (1978). Hemodialysis and enzymatic cleavage of methotrexate in man. European Journal of Cancer, 14, 787-792.
8. Djerassi, I., Ciesielka, W. and Kim, J. S. (1977). Removal of methotrexate by filtration-adsorption using charcoal filters or by hemodialysis. Cancer Treatment Reports, 61, 751-752.
9. Kintzel, P. E. and Dorrt, R. T. (1995). Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treatment Reviews, 21, 33-64.
10. Nirenberg, A., Mosende, C., Mehta, B. M., Gisolfi, A. L. and Rosen, G. (1977). High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treatment Reports, 61, 779-783.
11. Whidemann, B. C., Hetherington, M. L., Murphy, R. F., Balis, F. M. and Adamson, P. C. (1995). Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxocity. Cancer, 76, 521-526.